Biological interactions of carbon-based nanomaterials: From coronation to degradation

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 12, Issue 2, 2016, Pages 333-351

  Bhattacharya, Kunal ^a   Mukherjee, Sourav P ^a   Gallud, Audrey ^a   Burkert, Seth C ^b   Bistarelli, Silvia ^c   Bellucci, Stefano ^c   Bottini, Massimo ^d,e   Star, Alexander ^b   Fadeel, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c INFN LABORATORI NAZIONALI DI FRASCATI   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

^e BURNHAM INSTITUTE   (United States)

Author keywords

Bio corona; Biodegradation; Carbon nanotubes; Fullerenes; Graphene oxide; Nanodiamonds

Indexed keywords

BIODEGRADATION; BIOLOGICAL MATERIALS; CARBON NANOTUBES; FULLERENES; GRAPHENE; MEDICAL APPLICATIONS; MOLECULAR BIOLOGY; NANODIAMONDS; NANOTUBES; SURFACE TREATMENT; YARN;

BIO-CORONA; BIODISTRIBUTIONS; BIOLOGICAL INTERACTIONS; BIOMEDICAL APPLICATIONS; COMPETENT CELLS; ENZYMATIC DEGRADATION; GRAPHENE OXIDES; POTENTIAL IMPACTS;

NANOSTRUCTURED MATERIALS;

CARBON; CARBON NANOTUBE; FULLERENE DERIVATIVE; GRAPHENE OXIDE; MULTI WALLED NANOTUBE; NANODIAMOND; NANOMATERIAL; SINGLE WALLED NANOTUBE; BIOMATERIAL; GRAPHITE; OXIDE; PROTEIN CORONA;

BIOCOMPATIBILITY; BIODEGRADATION; BIOMEDICINE; DRUG DELIVERY SYSTEM; ENZYMATIC DEGRADATION; HUMAN; IMAGING; NANOMEDICINE; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; SURFACE PROPERTY; ANIMAL; BIOCATALYSIS; CHEMISTRY; LIPID METABOLISM; METABOLISM; MOLECULAR MODEL;

ANIMALS; BIOCATALYSIS; BIOCOMPATIBLE MATERIALS; CARBON; FULLERENES; GRAPHITE; HUMANS; LIPID METABOLISM; MODELS, MOLECULAR; NANOSTRUCTURES; NANOTUBES, CARBON; OXIDES; PROTEIN CORONA;

EID: 84961297663     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2015.11.011     Document Type: Review

References (172)

1. Fadeel B. Nanosafety: towards safer design of nanomedicines. J Intern Med 2013, 274:578-580.
2. Langer R., Weissleder R. Nanotechnology. JAMA 2015, 313:135-136.
3. Mundra R.V., Wu X., Sauer J., Dordick J.S., Kane R.S. Nanotubes in biological applications. Curr Opin Biotechnol 2014, 28:25-32.
4. Chen D., Dougherty C.A., Zhu K., Hong H. Theranostic applications of carbon nanomaterials in cancer: focus on imaging and cargo delivery. J Control Release 2015, 210:230-245.
5. Tonelli F.M., Goulart V.A., Gomes K.N., Ladeira M.S., Santos A.K., Lorençon E., et al. Graphene-based nanomaterials: biological and medical applications and toxicity. Nanomedicine (Lond) 2015, 10:2423-2450.
6. Farrera C., Bhattacharya K., Lazzaretto B., Andón F.T., Hultenby K., Kotchey G.P., et al. Extracellular entrapment and degradation of single-walled carbon nanotubes. Nanoscale 2014, 6:6974-6983.
7. Kunzmann A., Andersson B., Thurnherr T., Krug H., Scheynius A., Fadeel B. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 1810, 2011:361-373.
8. Monopoli M.P., Åberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012, 7:779-786.
9. Farrera C., Fadeel B. It takes two to tango: understanding the interactions between engineered nanomaterials and the immune system. Eur J Pharm Biopharm 2015, 95:3-12.
10. 60: Buckminsterfullerene. Nature 1985, 318:162-163.
11. Iijima S. Helical microtubules of graphitic carbon. Nature 1991, 354:56-58.
12. Monthioux M., Kuznetsov V.L. Who should be given credit for the discovery of carbon nanotubes?. Carbon 2006, 44:1621-1623.
13. Novoselov K.S., Geim A.K., Morozov S.V., Jiang D., Zhang Y., Dubonos S.V., et al. Electric field effect in atomically thin carbon films. Science 2004, 306:666-669.
14. Ferrari A.C., Bonaccorso F., Fal'ko V., Novoselov K.S., Roche S., Bøggild P., et al. Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems. Nanoscale 2015, 7:4598-4810.
15. Mochalin V.N., Shenderova O., Ho D., Gogotsi Y. The properties and applications of nanodiamonds. Nat Nanotechnol 2011, 7:11-23.
16. Park K. Facing the truth about nanotechnology in drug delivery. ACS Nano 2013, 7:7442-7447.
17. Ding X., Liu H., Fan Y. Graphene-based materials in regenerative medicine. Adv Healthc Mater 2015, 4:1451-1468.
18. Kane A.B., Hurt R.H. Nanotoxicology: the asbestos analogy revisited. Nat Nanotechnol 2008, 3:378-379.
19. Shvedova A.A., Pietroiusti A., Fadeel B., Kagan V.E. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol Appl Pharmacol 2012, 261:121-133.
20. Bhattacharya K., Andón F.T., El-Sayed R., Fadeel B. Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation. Adv Drug Deliv Rev 2013, 65:2087-2097.
21. Grosse Y., Loomis D., Guyton K.Z., Lauby-Secretan B., El Ghissassi F., Bouvard V., et al. International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol 2014, 15:1427-1428.
22. Sanchez V.C., Jachak A., Hurt R.H., Kane A.B. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem Res Toxicol 2012, 25:15-34.
23. Bussy C., Ali-Boucetta H., Kostarelos K. Safety considerations for graphene: lessons learnt from carbon nanotubes. Acc Chem Res 2013, 46:692-701.
24. Godwin H., Nameth C., Avery D., Bergeson L.L., Bernard D., Beryt E., et al. Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano 2015, 9:3409-3417.
25. Pescatori M., Bedognetti D., Venturelli E., Ménard-Moyon C., Bernardini C., Muresu E., et al. Functionalized carbon nanotubes as immunomodulator systems. Biomaterials 2013, 34:4395-4403.
26. Meunier E., Coste A., Olagnier D., Authier H., Lefèvre L., Dardenne C., et al. Double-walled carbon nanotubes trigger IL-1β release in human monocytes through Nlrp3 inflammasome activation. Nanomedicine 2012, 8:987-995.
27. Palomäki J., Välimäki E., Sund J., Vippola M., Clausen P.A., Jensen K.A., et al. Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. ACS Nano 2011, 5:6861-6870.
28. Yang M., Flavin K., Kopf I., Radics G., Hearnden C.H., McManus G.J. Functionalization of carbon nanoparticles modulates inflammatory cell recruitment and NLRP3 inflammasome activation. Small 2013, 9:4194-4206.
29. Boraschi D., Costantino L., Italiani P. Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine (Lond) 2012, 7:121-131.
30. Sydlik S.A., Jhunjhunwala S., Webber M.J., Anderson D.G., Langer R. In vivo compatibility of graphene oxide with differing oxidation states. ACS Nano 2015, 9:3866-3874.
31. Tkach A.V., Shurin G.V., Shurin M.R., Kisin E.R., Murray A.R., Young S.H., et al. Direct effects of carbon nanotubes on dendritic cells induce immune suppression upon pulmonary exposure. ACS Nano 2011, 5:5755-5762.
32. Tkach A.V., Yanamala N., Stanley S., Shurin M.R., Shurin G.V., Kisin E.R., et al. Graphene oxide, but not fullerenes, targets immunoproteasomes and suppresses antigen presentation by dendritic cells. Small 2013, 9:1686-1690.
33. Shurin M.R., Yanamala N., Kisin E.R., Tkach A.V., Shurin G.V., Murray A.R., et al. Graphene oxide attenuates Th2-type immune responses, but augments airway remodeling and hyperresponsiveness in a murine model of asthma. ACS Nano 2014, 8:5585-5599.
34. Bhirde A.A., Patel V., Gavard J., Zhang G., Sousa A.A., Masedunskas A., et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. ACS Nano 2009, 3:307-316.
35. Kam N.W., O'Connell M., Wisdom J.A., Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A 2005, 102:11600-11605.
36. Kostarelos K., Lacerda L., Pastorin G., Wu W., Wieckowski S., Luangsivilay J., et al. Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotechnol 2007, 2:108-113.
37. Al-Jamal K.T., Gherardini L., Bardi G., Nunes A., Guo C., Bussy C., et al. Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci U S A 2011, 108:10952-10957.
38. Sacchetti C., Liu-Bryan R., Magrini A., Rosato N., Bottini N., Bottini M. Polyethylene-glycol-modified single-walled carbon nanotubes for intra-articular delivery to chondrocytes. ACS Nano 2014, 8:12280-12291.
39. Novoselov K.S., Fal'ko V.I., Colombo L., Gellert P.R., Schwab M.G., Kim K. A roadmap for graphene. Nature 2012, 490:192-200.
40. Yang K., Zhang S., Zhang G., Sun X., Lee S.T., Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett 2010, 10:3318-3323.
41. Yang K., Hu L., Ma X., Ye S., Cheng L., Shi X., et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater 2012, 24:1868-1872.
42. Ma X., Tao H., Yang K., Feng L., Cheng L., Shi X., et al. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res 2012, 5:199-212.
43. Qin S.Y., Feng J., Rong L., Jia H.Z., Chen S., Liu X.J., et al. Theranostic GO-based nanohybrid for tumor induced imaging and potential combinational tumor therapy. Small 2014, 10:599-608.
44. Dellinger A., Zhou Z., Connor J., Madhankumar A.B., Pamujula S., Sayes C.M., et al. Application of fullerenes in nanomedicine: an update. Nanomedicine (Lond) 2013, 8:1191-1208.
45. Maeda-Mamiya R., Noiri E., Isobe H., Nakanishi W., Okamoto K., Doi K., et al. In vivo gene delivery by cationic tetraamino fullerene. Proc Natl Acad Sci U S A 2010, 107:5339-5344.
46. Lu X., Feng L., Akasaka T., Nagase S. Current status and future developments of endohedral metallofullerenes. Chem Soc Rev 2012, 41:7723-7760.
47. 22 and its implication for de novo design of nanomedicine. Proc Natl Acad Sci U S A 2012, 109:15431-15436.
48. Balogh L.P. Caging cancer. Nanomedicine 2015, 11:867-869.
49. Pan Y., Wang L., Kang S.G., Lu Y., Yang Z., Huynh T., et al. Gd-metallofullerenol nanomaterial suppresses pancreatic cancer metastasis by inhibiting the interaction of histone deacetylase 1 and metastasis-associated protein 1. ACS Nano 2015, 9:6826-6836.
50. Liu Y., Chen C., Qian P., Lu X., Sun B., Zhang X., et al. Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell-specific inhibitor. Nat Commun 2015, 6:5988-6005.
51. Gallud A., Fadeel B. Keeping it small: towards a molecular definition of nanotoxicology. Eur J Nanomedicine 2015, 7:143-151.
52. Fletcher J.I., Haber M., Henderson M.J., Norris M.D. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 2010, 10:147-156.
53. Prados J., Melguizo C., Ortiz R., Vélez C., Alvarez P.J., Arias J.L., et al. Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Anticancer Agents Med Chem 2012, 12:1058-1070.
54. Farokhzad O.C., Langer R. Impact of nanotechnology on drug delivery. ACS Nano 2009, 3:16-20.
55. Chow E.K., Zhang X.Q., Chen M., Lam R., Robinson E., Huang H., et al. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment. Sci Transl Med 2011, 3. 73ra21-32.
56. Wang X., Low X.C., Hou W., Abdullah L.N., Toh T.B., Mohd Abdul Rashid M., et al. Epirubicin-adsorbed nanodiamonds kill chemoresistant hepatic cancer stem cells. ACS Nano 2014, 8:12151-12166.
57. Yoo J.M., Kang J.H., Hong B.H. Graphene-based nanomaterials for versatile imaging studies. Chem Soc Rev 2015, 44:4835-4852.
58. De la Zerda A., Zavaleta C., Keren S., Vaithilingam S., Bodapati S., Liu Z., et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. Nat Nanotechnol 2008, 3:557-562.
59. Ghosh D., Bagley A.F., Na Y.J., Birrer M.J., Bhatia S.N., Belcher A.M. Deep, noninvasive imaging and surgical guidance of submillimeter tumors using targeted M13-stabilized single-walled carbon nanotubes. Proc Natl Acad Sci U S A 2014, 111:13948-13953.
60. Delogu L.G., Vidili G., Venturelli E., Ménard-Moyon C., Zoroddu M.A., Pilo G., et al. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proc Natl Acad Sci U S A 2012, 109:16612-16617.
61. Shi X., Gong H., Li Y., Wang C., Cheng L., Liu Z. Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy. Biomaterials 2013, 34:4786-4793.
62. Ge J., Lan M., Zhou B., Liu W., Guo L., Wang H., et al. A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation. Nat Commun 2014, 5:4596-4603.
63. Shi J., Wang L., Gao J., Liu Y., Zhang J., Ma R., et al. A fullerene-based multi-functional nanoplatform for cancer theranostic applications. Biomaterials 2014, 35:5771-5784.
64. Fu C.C., Lee H.Y., Chen K., Lim T.S., Wu H.Y., Lin P.K., et al. Characterization and application of single fluorescent nanodiamonds as cellular biomarkers. Proc Natl Acad Sci U S A 2007, 104:727-732.
65. Bellucci S. Toxicology, diagnostics, and therapy functions of nanomaterials. Handbook of nanophysics: nanomedicine and nanorobotics 2010, CRC Press, Boca Raton, FL. K.D. Sattler (Ed.).
66. Wang Z., Dai Z. Carbon nanomaterial-based electrochemical biosensors: an overview. Nanoscale 2015, 7:6420-6431.
67. Iverson N.M., Barone P.W., Shandell M., Trudel L.J., Sen S., Sen F., et al. In vivo biosensing via tissue-localizable near-infrared-fluorescent single-walled carbon nanotubes. Nat Nanotechnol 2013, 8:873-880.
68. Liu Y., Yu D., Zeng C., Miao Z., Dai L. Biocompatible graphene oxide-based glucose biosensors. Langmuir 2010, 26:6158-6160.
69. Jiang S., Cheng R., Wang X., Xue T., Liu Y., Nel A., et al. Real-time electrical detection of nitric oxide in biological systems with sub-nanomolar sensitivity. Nat Commun 2013, 4:2225-2231.
70. Ku S.H., Lee M., Park C.B. Carbon-based nanomaterials for tissue engineering. Adv Healthc Mater 2013, 2:244-260.
71. Cellot G., Cilia E., Cipollone S., Rancic V., Sucapane A., Giordani S., et al. Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts. Nat Nanotechnol 2009, 4:126-133.
72. Bosi S., Rauti R., Laishram J., Turco A., Lonardoni D., Nieus T., et al. From 2D to 3D: novel nanostructured scaffolds to investigate signalling in reconstructed neuronal networks. Sci Rep 2015, 5:9562-9572.
73. Thalhammer A., Edgington R.J., Cingolani L.A., Schoepfer R., Jackman R.B. The use of nanodiamond monolayer coatings to promote the formation of functional neuronal networks. Biomaterials 2010, 31:2097-2104.
74. Solanki A., Chueng S.T., Yin P.T., Kappera R., Chhowalla M., Lee K.B. Axonal alignment and enhanced neuronal differentiation of neural stem cells on graphene-nanoparticle hybrid structures. Adv Mater 2013, 25:5477-5482.
75. Docter D., Westmeier D., Markiewicz M., Stolte S., Knauer S.K., Stauber R.H. The nanoparticle biomolecule corona: lessons learned-challenge accepted?. Chem Soc Rev 2015, 44:6094-6121.
76. Fadeel B., Feliu N., Vogt C., Abdelmonem A.M., Parak W.J. Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013, 5:111-129.
77. Bhattacharya K., Farcal L.R., Fadeel B. Shifting identities of metal oxide nanoparticles: focus on inflammation. MRS Bull 2014, 39:970-975.
78. Salvati A., Pitek A.S., Monopoli M.P., Prapainop K., Bombelli F.B., Hristov D.R., et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol 2013, 8:137-143.
79. Kelly P.M., Åberg C., Polo E., O'Connell A., Cookman J., Fallon J., et al. Mapping protein binding sites on the biomolecular corona of nanoparticles. Nat Nanotechnol 2015, 10:472-479.
80. Hamad-Schifferli K. Exploiting the novel properties of protein coronas: emerging applications in nanomedicine. Nanomedicine (Lond) 2015, 10:1663-1674.
81. Dutta D., Sundaram S.K., Teeguarden J.G., Riley B.J., Fifield L.S., Jacobs J.M., et al. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol Sci 2007, 100:303-315.
82. Ge C., Du J., Zhao L., Wang L., Liu Y., Li D., et al. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci U S A 2011, 108:16968-16973.
83. Gao N., Zhang Q., Mu Q., Bai Y., Li L., Zhou H., et al. Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity. ACS Nano 2011, 5:4581-4591.
84. Hu W., Peng C., Lv M., Li X., Zhang Y., Chen N., et al. Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano 2011, 5:3693-3700.
85. Chong Y., Ge C., Yang Z., Garate J.A., Gu Z., Weber J.K., et al. Reduced cytotoxicity of graphene nanosheets mediated by blood-protein coating. ACS Nano 2015, 9:5713-5724.
86. Duan G., Kang S.G., Tian X., Garate J.A., Zhao L., Ge C., et al. Protein corona mitigates the cytotoxicity of graphene oxide by reducing its physical interaction with cell membrane. Nanoscale 2015, 7:15214-15224.
87. Gu Z., Yang Z., Wang L., Zhou H., Jimenez-Cruz C.A., Zhou R. The role of basic residues in the adsorption of blood proteins onto the graphene surface. Sci Rep 2015, 5:10873-10883.
88. Gu Z., Yang Z., Chong Y., Ge C., Weber J.K., Bell D.R., et al. Surface curvature relation to protein adsorption for carbon-based nanomaterials. Sci Rep 2015, 5:10886-10894.
89. Kapralov A.A., Feng W.H., Amoscato A.A., Yanamala N., Balasubramanian K., Winnica D.E., et al. Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano 2012, 6:4147-4156.
90. Gasser M., Rothen-Rutishauser B., Krug H.F., Gehr P., Nelle M., Yan B., et al. The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnol 2010, 8:31-39.
91. Huang P.J., Pautler R., Shanmugaraj J., Labbé G., Liu J. Inhibiting the VIM-2 metallo-β-lactamase by graphene oxide and carbon nanotubes. ACS Appl Mater Interfaces 2015, 7:9898-9903.
92. De M., Chou S.S., Dravid V.P. Graphene oxide as an enzyme inhibitor: modulation of activity of α-chymotrypsin. J Am Chem Soc 2011, 133:17524-17527.
93. Li J., Wu L.J., Guo S.S., Fu H.E., Chen G.N., Yang H.H. Simple colorimetric bacterial detection and high-throughput drug screening based on a graphene-enzyme complex. Nanoscale 2013, 5:619-623.
94. Jin L., Yang K., Yao K., Zhang S., Tao H., Lee S.T., et al. Functionalized graphene oxide in enzyme engineering: a selective modulator for enzyme activity and thermostability. ACS Nano 2012, 6:4864-4875.
95. Moghimi S.M. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth. J Control Release 2014, 190:556-562.
96. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M.L., Sim R.B. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol 2006, 43:193-201.
97. Hamad I., Christy Hunter A., Rutt K.J., Liu Z., Dai H., Moghimi S.M. Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol Immunol 2008, 45:3797-3803.
98. Tan X., Feng L., Zhang J., Yang K., Zhang S., Liu Z., et al. Functionalization of graphene oxide generates a unique interface for selective serum protein interactions. ACS Appl Mater Interfaces 2013, 5:1370-1377.
99. Moghimi S.M., Wibroe P.P., Wu L., Farhangrazi Z.S. Insidious pathogen-mimicking properties of nanoparticles in triggering the lectin pathway of the complement system. Eur J Nanomedicine 2015, 7:263-268.
100. Bottini M., Rosato N., Bottini N. PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead. Biomacromolecules 2011, 12:3381-3393.
101. Pombo García K., Zarschler K., Barbaro L., Barreto J.A., O'Malley W., Spiccia L., et al. Zwitterionic-coated "stealth" nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system. Small 2014, 10:2516-2529.
102. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Itty Ipe B., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
103. Yameen B., Choi W.I., Vilos C., Swami A., Shi J., Farokhzad O.C. Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release 2014, 190:485-499.
104. Krais A., Wortmann L., Hermanns L., Feliu N., Vahter M., Stucky S., et al. Targeted uptake of folic acid-functionalized iron oxide nanoparticles by ovarian cancer cells in the presence but not in the absence of serum. Nanomedicine 2014, 10:1421-1431.
105. Dai Q., Walkey C., Chan W.C. Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. Angew Chem Int Ed Engl 2014, 53:5093-5096.
106. Dai Q., Yan Y., Ang C.S., Kempe K., Kamphuis M.M., Dodds S.J., et al. Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas. ACS Nano 2015, 9:2876-2885.
107. Hadjidemetriou M., Al-Ahmady Z., Mazza M., Collins R.F., Dawson K., Kostarelos K. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles. ACS Nano 2015, 9:8142-8156.
108. Sacchetti C., Rapini N., Magrini A., Cirelli E., Bellucci S., Mattei M., et al. In vivo targeting of intratumor regulatory T cells using PEG-modified single-walled carbon nanotubes. Bioconjug Chem 2013, 24:852-858.
109. Hong H., Yang K., Zhang Y., Engle J.W., Feng L., Yang Y., et al. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano 2012, 6:2361-2370.
110. Hajipour M.J., Raheb J., Akhavan O., Arjmand S., Mashinchian O., Rahman M., et al. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. Nanoscale 2015, 7:8978-8994.
111. Moghimi S.M., Hunter A.C., Andresen T.L. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol 2012, 52:481-503.
112. Phillips M.A., Gran M.L., Peppas N.A. Targeted nanodelivery of drugs and diagnostics. Nano Today 2010, 5:143-159.
113. Blanco E., Shen H., Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 2015, 33:941-951.
114. Tasciotti E., Liu X., Bhavane R., Plant K., Leonard A.D., Price B.K., et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008, 3:151-157.
115. Cabral H., Matsumoto Y., Mizuno K., Chen Q., Murakami M., Kimura M., et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol 2011, 6:815-823.
116. Ali-Boucetta H., Kostarelos K. Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation. Adv Drug Deliv Rev 2013, 65:2111-2119.
117. Singh R., Pantarotto D., Lacerda L., Pastorin G., Klumpp C., Prato M., et al. Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A 2006, 103:3357-3362.
118. Ruggiero A., Villa C.H., Bander E., Rey D.A., Bergkvist M., Batt C.A., et al. Paradoxical glomerular filtration of carbon nanotubes. Proc Natl Acad Sci U S A 2010, 107:12369-12374.
119. Al-Jamal K.T., Nunes A., Methven L., Ali-Boucetta H., Li S., Toma F.M., et al. Degree of chemical functionalization of carbon nanotubes determines tissue distribution and excretion profile. Angew Chem Int Ed Engl 2012, 51:6389-6393.
120. Wang J.T., Fabbro C., Venturelli E., Menard-Moyon C., Chaloin O., Da Ros T., et al. The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo. Biomaterials 2014, 35:9517-9528.
121. Yang K., Wan J., Zhang S., Zhang Y., Lee S.T., Liu Z. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano 2011, 5:516-522.
122. Jasim D.A., Menard-Moyon C., Begin D., Bianco A., Kostarelos K. Tissue distribution and urinary excretion of intravenously administered chemically functionalized graphene oxide sheets. Chem Sci 2015, 6:3952-3964.
123. Wick P., Louw-Gaume A.E., Kucki M., Krug H.F., Kostarelos K., Fadeel B., et al. Classification framework for graphene-based materials. Angew Chem Int Ed Engl 2014, 53:7714-7718.
124. Cherukuri P., Gannon C.J., Leeuw T.K., Schmidt H.K., Smalley R.E., Curley S.A., et al. Mammalian pharmacokinetics of carbon nanotubes using intrinsic near-infrared fluorescence. Proc Natl Acad Sci U S A 2006, 103:18882-18886.
125. Yang S.T., Guo W., Lin Y., Deng X.Y., Wang H.F., Sun H.F., et al. Biodistribution of pristine single-walled carbon nanotubes in vivo. J Phys Chem C 2007, 111:17761-17764.
126. Chen S., Xiong C., Liu H., Wan Q., Hou J., He Q., et al. Mass spectrometry imaging reveals the sub-organ distribution of carbon nanomaterials. Nat Nanotechnol 2015, 10:176-182.
127. Huang X., Zhang F., Zhu L., Choi K.Y., Guo N., Guo J., et al. Effect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dots. ACS Nano 2013, 7:5684-5693.
128. Vachet R.W. Molecular histology: more than a picture. Nat Nanotechnol 2015, 10:103-104.
129. Girish C.M., Sasidharan A., Gowd G.S., Nair S., Koyakutty M. Confocal Raman imaging study showing macrophage mediated biodegradation of graphene in vivo. Adv Healthc Mater 2013, 2:1489-1500.
130. Liu Z., Cai W., He L., Nakayama N., Chen K., Sun X., et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat Nanotechnol 2007, 2:47-52.
131. Sacchetti C., Motamedchaboki K., Magrini A., Palmieri G., Mattei M., Bernardini S., et al. Surface polyethylene glycol conformation influences the protein corona of polyethylene glycol-modified single-walled carbon nanotubes: potential implications on biological performance. ACS Nano 2013, 7:1974-1989.
132. Yuan Y.Y., Mao C.Q., Du X.J., Du J.Z., Wang F., Wang J. Surface charge switchable nanoparticles based on zwitterionic polymer for enhanced drug delivery to tumor. Adv Mater 2012, 24:5476-5480.
133. Smith B.R., Ghosn E.E., Rallapalli H., Prescher J.A., Larson T., Herzenberg L.A., et al. Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat Nanotechnol 2014, 9:481-487.
134. Mantovani A., Allavena P. The interaction of anticancer therapies with tumor-associated macrophages. J Exp Med 2015, 212:435-445.
135. Kotchey G.P., Zhao Y., Kagan V.E., Star A. Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo. Adv Drug Deliv Rev 2013, 65:1921-1932.
136. Mukherjee S.P., Bhattacharya K., Fadeel B. Carbon-based nanomaterials: from biodegradation to biomedical applications. Immune effects of biopharmaceuticals and nanomedicines 2015, Pan Stanford Publishing, Singapore. R. Bawa, J. Szebeni (Eds.).
137. Ye R., Xiang C., Lin J., Peng Z., Huang K., Yan Z., et al. Coal as an abundant source of graphene quantum dots. Nat Commun 2013, 4:2943-2949.
138. Dong Y., Wan L., Cai J., Fang Q., Chi Y., Chen G. Natural carbon-based dots from humic substances. Sci Rep 2015, 5:10037-10044.
139. Su Z., Zhou W., Zhang Y. New insight into the soot nanoparticles in a candle flame. Chem Commun 2011, 47:4700-4702.
140. Li D., Mueller M.B., Gilje S., Kaner R.B., Wallace G.G. Processable aqueous dispersions of graphene nanosheets. Nat Nanotechnol 2008, 3:101-105.
141. Liu L., Ryu S., Tomasik M.R., Stolyarova E., Jung N., Hybertsen M.S., et al. Graphene oxidation: thickness-dependent etching and strong chemical doping. Nano Lett 2008, 8:1965-1970.
142. Allen B.L., Kichambre P.D., Gou P., Vlasova I.I., Kapralov A.A., Konduru N., et al. Biodegradation of single-walled carbon nanotubes through enzymatic catalysis. Nano Lett 2008, 8:3899-3903.
143. Allen B.L., Kotchey G.P., Chen Y., Yanamala N.V.K., Klein-Seetharaman J., Kagan V.E., et al. Mechanistic investigations of horseradish peroxidase-catalyzed degradation of single-walled carbon nanotubes. J Am Chem Soc 2009, 131:17194-17205.
144. Zhao Y., Allen B.L., Star A. Enzymatic degradation of multiwalled carbon nanotubes. J Phys Chem A 2011, 115:9536-9544.
145. Russier J., Menard-Moyon C., Venturelli E., Gravel E., Marcolongo G., Meneghetti M., et al. Oxidative biodegradation of single- and multi-walled carbon nanotubes. Nanoscale 2011, 3.
146. Flores-Cervantes D.X., Maes H.M., Schaffer A., Hollender J., Kohler H.-P.E. Slow biotransformation of carbon nanotubes by horseradish peroxidase. Environ Sci Technol 2014, 48:4826-4834.
147. Kotchey G.P., Allen B.L., Vedala H., Yanamala N., Kapralov A.A., Tyurina Y.Y., et al. The enzymatic oxidation of graphene oxide. ACS Nano 2011, 5:2098-2108.
148. 60 fullerol. Environ Sci Technol 2009, 43:3162-3168.
149. Berry T.D., Filley T.R., Blanchette R.A. Oxidative enzymatic response of white-rot fungi to single-walled carbon nanotubes. Environ Pollut 2014, 193:197-204.
150. Lalwani G., Xing W., Sitharaman B. Enzymatic degradation of oxidized and reduced graphene nanoribbons by lignin peroxidase. J Mater Chem B Mater Biol Med 2014, 2:6354-6362.
151. Zhang L., Petersen E.J., Habteselassie M.Y., Mao L., Huang Q. Degradation of multiwall carbon nanotubes by bacteria. Environ Pollut 2013, 181:335-339.
152. Liu L., Zhu C., Fan M., Chen C., Huang Y., Hao Q., et al. Oxidation and degradation of graphitic materials by naphthalene-degrading bacteria. Nanoscale 2015, 7:13619-13628.
153. Kagan V.E., Konduru N.V., Feng W., Allen B.L., Conroy J., Volkov Y., et al. Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat Nanotechnol 2010, 5:354-359.
154. Andón F.T., Kapralov A.A., Yanamala N., Feng W., Baygan A., Chambers B.J., et al. Biodegradation of single-walled carbon nanotubes by eosinophil peroxidase. Small 2013, 9:2721-2729.
155. Bhattacharya K., El-Sayed R., Andon F.T., Mukherjee S.P., Gregory J., Li H., et al. Lactoperoxidase-mediated degradation of single-walled carbon nanotubes in the presence of pulmonary surfactant. Carbon 2015, 91:506-517.
156. Bai H., Kotchey G.P., Saidi W.A., Bythell B.J., Jarvis J.M., Marshall A.G., et al. Insight into the mechanism of graphene oxide degradation via the photo-fenton reaction. J Phys Chem C 2014, 118:10519-10529.
157. Pan S., Sardesai N.P., Liu H., Rusling J.F. Assessing DNA damage from enzyme-oxidized single-walled carbon nanotubes. Toxicol Res 2013, 2:375-378.
158. Lu N., Li J., Tian R., Peng Y.Y. Binding of human serum albumin to single-walled carbon nanotubes activated neutrophils to increase production of hypochlorous acid, the oxidant capable of degrading nanotubes. Chem Res Toxicol 2014, 27:1070-1077.
159. Shvedova A.A., Kapralov A.A., Feng W.H., Kisin E.R., Murray A.R., Mercer R.R., et al. Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice. PLoS One 2012, 7:e30923-e30931.
160. Kagan V.E., Kapralov A.A., St.Croix C.M., Watkins S.C., Kisin E.R., Kotchey G.P., et al. Lung macrophages "digest" carbon nantubes using a superoxide/peroxynitrite oxidative pathway. ACS Nano 2014, 8:5610-5621.
161. Zhang M., Yang M., Bussy C., Iijima S., Kostarelos K., Yudasaka M. Biodegradation of carbon nanohorns in macrophage cells. Nanoscale 2015, 7:2834-2840.
162. Elgrabli D., Dachraoui W., Ménard-Moyon C., Liu X.J., Bégin D., Bégin-Colin S. Carbon nanotube degradation in macrophages: live nanoscale monitoring and understanding of biological pathway. ACS Nano 2015, 9:10113-10124.
163. Nunes A., Bussy C., Gherardini L., Meneghetti M., Herrero M.A., Bianco A., et al. In vivo degradation of functionalized carbon nanotubes after stereotactic administration in the brain cortex. Nanomedicine (Lond) 2012, 7:1485-1494.
164. Bhattacharya K., Sacchetti C., El-Sayed R., Fornara A., Kotchey G.P., Gaugler J.A., et al. Enzymatic 'stripping' and degradation of PEGylated carbon nanotubes. Nanoscale 2014, 6:14686-14690.
165. Yang S.T., Wang H., Meziani M.J., Liu Y., Wang X., Sun Y.P. Biodefunctionalization of functionalized single-walled carbon nanotubes in mice. Biomacromolecules 2009, 10:2009-2012.
166. Allen B.L., Kichambare P.D., Star A. Synthesis, characterization, and manipulation of nitrogen-doped carbon nanotube cups. ACS Nano 2008, 2:1914-1920.
167. Zhao Y., Burkert S.C., Tang Y., Sorescu D.C., Kapralov A.A., Shurin G.V., et al. Nano-gold corking and enzymatic uncorking of carbon nanotube cups. J Am Chem Soc 2015, 137:675-684.
168. Seo W., Kapralov A.A., Shurin G.V., Shurin M.R., Kagan V.E., Star A. Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications. Nanoscale 2015, 7:8689-8694.
169. Kurapati R., Russier J., Squillaci M.A., Trossi E., Menard-Moyon C., Del Rio-Castillo A.E., et al. Dispersibility-dependent biodegradation of graphene oxide by myeloperoxidase. Small 2015, 11:3985-3994.
170. Li Y., Feng L., Shi X., Wang X., Yang Y., Yang K., et al. Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene. Small 2014, 10:1544-1554.
171. Andón F.T., Fadeel B. Nanotoxicology: towards safety-by-design. Nano-oncologicals: new targeting and delivery approaches 2014, Springer, Heidelberg. M.J. Alonso, M. Garcia-Fuentes (Eds.).
172. Fadel T.R., Fahmy T.M. Immunotherapy applications of carbon nanotubes: from design to safe applications. Trends Biotechnol 2014, 32:198-209.